214 related articles for article (PubMed ID: 28344059)
1. Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation.
Jordan K; Pontoppidan P; Uhlving HH; Kielsen K; Burrin DG; Weischendorff S; Christensen IJ; Jørgensen MH; Heilmann C; Sengeløv H; Müller K
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1170-1176. PubMed ID: 28344059
[TBL] [Abstract][Full Text] [Related]
2. Associations between gastrointestinal toxicity, micro RNA and cytokine production in patients undergoing myeloablative allogeneic stem cell transplantation.
Pontoppidan PL; Jordan K; Carlsen AL; Uhlving HH; Kielsen K; Christensen M; Ifversen M; Nielsen CH; Sangild P; Heegaard NH; Heilmann C; Sengeløv H; Müller K
Int Immunopharmacol; 2015 Mar; 25(1):180-8. PubMed ID: 25614225
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with liver injury and impact of liver injury on transplantation-related mortality in pediatric recipients of allogeneic hematopoietic stem cell transplantation.
Radhakrishnan K; Bishop J; Jin Z; Kothari K; Bhatia M; George D; Garvin JH; Martinez M; Ovchinsky N; Lobritto S; Elsayed Y; Satwani P
Biol Blood Marrow Transplant; 2013 Jun; 19(6):912-7. PubMed ID: 23467127
[TBL] [Abstract][Full Text] [Related]
4. Morphine consumption is associated with systemic inflammation in children undergoing allogeneic hematopoietic stem cell transplantation.
De Pietri S; Nielsen BN; Ifversen M; Kielsen K; Müller KG
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):285-291. PubMed ID: 30892107
[No Abstract] [Full Text] [Related]
5. Incidence, etiology, and risk factors for liver dysfunction in children following hematopoietic stem cell transplantation.
Subbarao G; Haut PR; Johnson CS; Gowan D; Molleston JP
Pediatr Transplant; 2006 Sep; 10(6):682-9. PubMed ID: 16911491
[TBL] [Abstract][Full Text] [Related]
6. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-Like Peptide-1 Is Associated With Systemic Inflammation in Pediatric Patients Treated With Hematopoietic Stem Cell Transplantation.
Ebbesen M; Kissow H; Hartmann B; Kielsen K; Sørensen K; Stinson SE; Frithioff-Bøjsøe C; Esmann Fonvig C; Holm JC; Hansen T; Holst JJ; Müller KG
Front Immunol; 2021; 12():793588. PubMed ID: 34956226
[TBL] [Abstract][Full Text] [Related]
8. T cell reconstitution in allogeneic haematopoietic stem cell transplantation: prognostic significance of plasma interleukin-7.
Kielsen K; Jordan KK; Uhlving HH; Pontoppidan PL; Shamim Z; Ifversen M; Heilmann C; Nielsen CH; Sengeløv H; Ryder LP; Müller KG
Scand J Immunol; 2015 Jan; 81(1):72-80. PubMed ID: 25263171
[TBL] [Abstract][Full Text] [Related]
9. Reduced Plasma Amino Acid Levels During Allogeneic Hematopoietic Stem Cell Transplantation Are Associated with Systemic Inflammation and Treatment-Related Complications.
Weischendorff S; Kielsen K; Nederby M; Schmidt L; Burrin D; Heilmann C; Ifversen M; Sengeløv H; Mølgaard C; Müller K
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1432-1440. PubMed ID: 30910606
[TBL] [Abstract][Full Text] [Related]
10. Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome.
Hattori N; Saito B; Sasaki Y; Shimada S; Murai S; Abe M; Baba Y; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Kabasawa N; Tsukamoto H; Uto Y; Ariizumi H; Yanagisawa K; Harada H; Nakamaki T
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1841-1847. PubMed ID: 29753837
[TBL] [Abstract][Full Text] [Related]
11. Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.
Guièze R; Damaj G; Pereira B; Robin M; Chevallier P; Michallet M; Vigouroux S; Beguin Y; Blaise D; El Cheikh J; Roos-Weil D; Thiebaut A; Rohrlich PS; Huynh A; Cornillon J; Contentin N; Suarez F; Lioure B; Mohty M; Maillard N; Clement L; François S; Guillerm G; Yakoub-Agha I
Biol Blood Marrow Transplant; 2016 Feb; 22(2):240-247. PubMed ID: 26256942
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
Nair AP; Barnett MJ; Broady RC; Hogge DE; Song KW; Toze CL; Nantel SH; Power MM; Sutherland HJ; Nevill TJ; Abou Mourad Y; Narayanan S; Gerrie AS; Forrest DL
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1437-44. PubMed ID: 25865648
[TBL] [Abstract][Full Text] [Related]
13. Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: a study of 455 patients.
Barba P; Piñana JL; Fernández-Avilés F; Perez-Simón JA; Martino R; López-Guerrero E; Valcárcel D; Rovira M; Novelli S; Campos-Varela I; López-Anglada L; Vidal X; López Corral L; Carreras E; Sierra J
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1653-61. PubMed ID: 21586334
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.
Chamseddine AN; Willekens C; De Botton S; Bourhis JH
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S129-40. PubMed ID: 26297265
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of TNF-alpha, IL-1beta and IFN-gamma levels at early phase after allogeneic hematopoietic stem cell transplantation].
Gao HL; Sun AN; Han Y; Zhang W; Hu XH; Wu DP; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1321-5. PubMed ID: 19840475
[TBL] [Abstract][Full Text] [Related]
16. Assessment of immune reconstitution status in recipients of a successful hematopoietic stem cell transplant from peripheral blood after reduced intensity conditioning.
Jaime-Pérez JC; Villarreal-Villarreal CD; Méndez-Ramírez N; Vázquez-Garza E; Salazar-Riojas R; Gómez-Almaguer D
Blood Cells Mol Dis; 2016 May; 58():52-6. PubMed ID: 27067489
[TBL] [Abstract][Full Text] [Related]
17. The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index.
Birninger N; Bornhäuser M; Schaich M; Ehninger G; Schetelig J
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1822-32. PubMed ID: 21708108
[TBL] [Abstract][Full Text] [Related]
18. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Study of Central Nervous System Invasive Fungal Disease after Allogeneic Stem Cell Transplantation: Risk Factors, Clinical Characteristics, and Outcomes.
Sun YQ; Liu ZY; Huang XJ; Yan CH; Xu LP; Zhang XH; Liu KY; Wang Y
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1158-1164. PubMed ID: 28390982
[TBL] [Abstract][Full Text] [Related]
20. Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia.
Kudo K; Muramatsu H; Yoshida N; Kobayashi R; Yabe H; Tabuchi K; Kato K; Koh K; Takahashi Y; Hashii Y; Kawano Y; Inoue M; Cho Y; Sakamaki H; Kawa K; Kato K; Suzuki R; Kojima S
Bone Marrow Transplant; 2015 Oct; 50(10):1312-5. PubMed ID: 26121106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
